ARS
BIIB icon

Adirondack Retirement Specialists’s Biogen BIIB Stock Holding History

Adirondack Retirement Specialists’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$1.99K – 42
2023
Q2 		$1.99K Hold
7
– – ﹤0.01% 100
2023
Q1 		$1.93K Hold
7
– – ﹤0.01% 112
2022
Q4 		$1.94K Hold
7
– – ﹤0.01% 93
2022
Q3 		$2K Buy
+7
New +$1.49K ﹤0.01% 92

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Adirondack Retirement Specialists's BIIB Position: Q3 2023 in Review

Adirondack Retirement Specialists sold out of Biogen (BIIB) in Q3 2023, closing a stake of 7 shares — an estimated $1.99K sold.

Adirondack Retirement Specialists first reported a position in BIIB in Q3 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Adirondack Retirement Specialists reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Adirondack Retirement Specialists sold 7 Biogen shares in Q3 2023, an estimated $1.99K.
  • Adirondack Retirement Specialists first reported a position in Biogen in Q3 2022 and held it in 4 quarters.
  • Adirondack Retirement Specialists's Biogen position peaked at $2K in Q3 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Adirondack Retirement Specialists's 13F filing for Q3 2023, filed 24 Oct 2023.